Source: Breathe 2005; 1: 247



Rating:

Share or cite this content

Citations should be made in the following way:
P. Van Schil. Value of PET scanning in clinical T1N0M0 adenocarcinoma. Breathe 2005; 1: 247

Member's Comments

No comment yet.

Related content which might interest you: Value of positron emission tomography parameters for the prognosis of small-cell lung carcinoma Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Is invasive staging necessary for NSCLC cases with no mediastinal N2 in PET/CT and thorax CT imaging? Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008 Combining bronchoscopy and PET for assessment and staging of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 678s Year: 2005 CT-PET scanning in suspected lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 672s Year: 2004 Synchronous primary malignancies identified during staging 18F-FDG PET scan in lung cancer patients Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 Role of CT and PET in detecting non-aggressive stage IA NSCLC Source: International Congress 2016 – The stage I non-small-cell lung cancer Year: 2016 Mediastinoscopy versus CT and PET in preoperative N-staging of lung cancer Source: Annual Congress 2009 - Current challenges in thoracic surgery Year: 2009 Preoperative evaluation of locally advanced non-small cell lung cancer after induction therapy by positron emission tomography with F-18-fluorodeoxyglucose (FDG-PET) Source: Eur Respir J 2004; 24: Suppl. 48, 457s Year: 2004 Incidental extra pulmonary abnormalities in positive emission tomography imaging with fluro-deoxyglucose done for lung cancer staging Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 The role of positron emission tomography scan in the preoperative staging of nonsmall cell lung cancer Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery Year: 2008 Computed tomography in staging for lung cancer Source: Eur Respir J 2002; 19: 40S-48S Year: 2002 Mediastinal lymph node staging in nonsmall cell lung cancer: comparison of positron emission tomography and mediastinoscopy Source: Annual Congress 2007 - Staging, diagnostic procedures and complex situations in thoracic surgery Year: 2007 Endobronchial ultrasound guided biopsy (EBUS–TBNA) for staging of patients with lung cancer without mediastinal involvement at positron emission tomography-computed tomography (PET-CT) Source: International Congress 2016 – Endosonography: EBUS/EUS (B) Year: 2016 Utility of PET/CT in staging of lung cancer: Results from 245 patients Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 Clinicopathologic comparison of computed tomography and positron emission tomography scanning for mediastinal staging in NSCLC Source: Annual Congress 2010 - Actual challenges in thoracic surgery Year: 2010 Comparative diagnostic accuracy of thoracic endosonography (EBUS/EUS-b) and integrated PET-CT in mediastinal staging of potentially operable patients with NSCLC. Source: Virtual Congress 2020 – Current and contemporary practices in endobronchial ultrasound Year: 2020 Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer Source: Eur Respir J 2007; 29: 995-1002 Year: 2007 Endobronchial ultrasound and PET positive nodes in bronchial carcinoma Source: Annual Congress 2006 - Lung cancer staging and miscellaneous Year: 2006 The role of FDG-PET scanning in the diagnosis of pulmonary nodules suspicious for lung cancer Source: International Congress 2015 – Advances in pneumonia management, COPD therapy and lung nodule evaluation Year: 2015 Prognostic impact of FDG-PET in recurrence of surgically treated non-small cell lung cancer Source: Annual Congress 2005 - Management of lung cancer: clinical problems Year: 2005